Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.

Health Care

Biotechnology

Universal Cells

Taku Yoshida

Michaela Anderson

David Fine

Chelsea Maguire

Katie Lombardo

Lisa Petek

Noboru Yamaji

Research and Development

Leadership Team

Operations and Facilities

Quality Assurance Team

Teams at Universal Cells

Research and Development

Research and Development

Leadership Team

Operations and Facilities

Quality Assurance Team